Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma
about
Mouse Models Recapitulating Human Adrenocortical Tumors: What Is Lacking?American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providersNext-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies.Pediatric adrenocortical tumors: what they can tell us on adrenal development and comparison with adult adrenal tumors.Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkersDevelopment of adrenal cortex zonation.Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study.Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples.Mouse models of adrenocortical tumors.Adrenocortical carcinoma is a lynch syndrome-associated cancerFirst case report of an adrenocortical carcinoma caused by a BRCA2 mutationAdjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma.Genetics and epigenetics of adrenocortical tumors.Adrenocortical growth and cancer.Diagnosis, treatment and outcome of adrenocortical cancer.5th International ACC Symposium: Hereditary Predisposition to Childhood ACC and the Associated Molecular Phenotype: 5th International ACC Symposium Session: Not Just for Kids!5th International ACC Symposium: An Outlook to Current and Future Research on the Biology of Adrenocortical Carcinoma: Diagnostic and Therapeutic Applications.Challenges in surgical pathology of adrenocortical tumours.A Novel TP53 Mutation Associated with TWIST1 and SIP1 Expression in an Aggressive Adrenocortical Carcinoma.Adrenocortical carcinoma
P2860
Q26740687-F9410D0A-1BFB-4692-9563-A524BB2DB057Q30416965-6AF28D55-7027-45DA-B583-D69E47DE414BQ34431264-AE33E184-FF41-427F-A8FF-9CAC09CBB011Q35094565-4827B72B-90C4-4214-9148-B041CA87452DQ35151124-92B2BA65-DE59-440B-BADB-CB1A506E9315Q35800278-954332B0-E739-4D0B-B4AF-D2BAFF0491FAQ35896015-22AA1F88-831C-41B9-8C22-81F32C484BABQ36228058-5EA0F170-7B03-4C1B-931A-96079178D85AQ36482758-5EB9D4A6-D23C-415D-8B10-2289CFAB3398Q37085859-C0BE44EB-594E-4682-B3CE-221D1467AF29Q37256959-3C296692-DE1F-48E8-9A32-9675FC0D587EQ37554806-8F729C19-8AC5-4D1F-9070-01AA54FEE5D5Q38162079-780BDE3A-7644-4BF2-BF90-931C8EA1054EQ38318638-B7578E84-6562-472B-95B4-B192F6D7D487Q38358503-B4342969-21AC-4CF7-A635-A52082DC0F3DQ38667422-48D87910-2342-467D-ABC4-BC961A7D34F4Q38668953-77406F6F-1D2E-45EE-A463-6B250F3F4DDAQ47576824-290A3F8D-5016-40C6-893B-8D3E1752D261Q48260919-E9CD1D97-0120-4161-AB84-532EBC976CCFQ57645859-3BF71BFC-0F19-45CA-B0E1-BACF18DD14BE
P2860
Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Prevalence of germline TP53 mu ...... with adrenocortical carcinoma
@ast
Prevalence of germline TP53 mu ...... with adrenocortical carcinoma
@en
type
label
Prevalence of germline TP53 mu ...... with adrenocortical carcinoma
@ast
Prevalence of germline TP53 mu ...... with adrenocortical carcinoma
@en
prefLabel
Prevalence of germline TP53 mu ...... with adrenocortical carcinoma
@ast
Prevalence of germline TP53 mu ...... with adrenocortical carcinoma
@en
P2093
P2860
P356
P1476
Prevalence of germline TP53 mu ...... with adrenocortical carcinoma
@en
P2093
Gary D Hammer
Jessica M Long
Jessica N Everett
Stephen B Gruber
Tobias Else
Victoria M Raymond
P2860
P304
P356
10.1210/JC.2012-2198
P407
P577
2012-11-21T00:00:00Z